Agencies › Drug Enforcement Administration
Who's commenting on Drug Enforcement Administration rules
31 companies and organizations have filed 34 comment letters on 8 proposed rules from the Drug Enforcement Administration. The most frequent commenter is Eisai Inc.. 1 rule is open for comment now.
- Comment letters
- 34
- Organizations
- 31
- Rules with letters
- 8
- Open for comment now
- 1
Open for comment now
- Extension of Reexportation Period. DEA-2026-1684 · due November 30, 2026 · 1 letter so far
Who comments most on Drug Enforcement Administration rules
- Eisai Inc. · 2 letters on 1 rule · Pharma & Medical Devices
- Johnson & Johnson Innovative Medicine · 2 letters on 2 rules · Pharma & Medical Devices
- Terrapin Legal · 2 letters on 1 rule · Other
- American Academy of Sleep Medicine · 1 letter on 1 rule · Healthcare
- American Association of Psychiatric Pharmacists (AAPP) · 1 letter on 1 rule · Pharma & Medical Devices
- American Pharmacists Association · 1 letter on 1 rule · Healthcare
- Amneal Pharmaceuticals, LLC · 1 letter on 1 rule · Pharma & Medical Devices
- Community Environmental Health Strategies LLC · 1 letter on 1 rule · Healthcare
- End Drug Shortages Alliance · 1 letter on 1 rule · Pharma & Medical Devices
- Extalvo, Inc. · 1 letter on 1 rule · Other
- Foundation for Drug Policy Solutions · 1 letter on 1 rule · Pharma & Medical Devices
- Fresenius Kabi · 1 letter on 1 rule · Pharma & Medical Devices
- GFMD Ltd. · 1 letter on 1 rule · Other
- Green And Gone, LLC · 1 letter on 1 rule · Other
- Idorsia Pharmaceuticals US Inc. · 1 letter on 1 rule · Pharma & Medical Devices
- Journal of Psychedelic Psychiatry · 1 letter on 1 rule · Healthcare
- Merck & Co., Inc. · 1 letter on 1 rule · Pharma & Medical Devices
- Micro-Waste Corporation · 1 letter on 1 rule · Other
- Mikart, LLC · 1 letter on 1 rule · Pharma & Medical Devices
- National Waste & Recycling Association · 1 letter on 1 rule · Manufacturing & Chemicals
- New Changes Upon You · 1 letter on 1 rule · Other
- Pfizer, Inc. · 1 letter on 1 rule · Pharma & Medical Devices
- Pinnacle Treatment Centers · 1 letter on 1 rule · Advocacy & Nonprofits
- Pinney Associates, Inc. · 1 letter on 1 rule · Other
- Pistoia Alliance · 1 letter on 1 rule · Advocacy & Nonprofits
- Premier Inc · 1 letter on 1 rule · Healthcare
- RMMS · 1 letter on 1 rule · Other
- SUNY Delhi Public Policy Class. · 1 letter on 1 rule · Advocacy & Nonprofits
- The Association for Accessible Medicines (AAM) · 1 letter on 1 rule · Pharma & Medical Devices
- The STARR Coalition · 1 letter on 1 rule · Healthcare
Letters by industry
Pharma & Medical Devices 14 Other 9 Healthcare 7 Advocacy & Nonprofits 3 Manufacturing & Chemicals 1
Letters by year
Rules and how many letters each drew
- Extension of Reexportation Period. DEA-2026-1684 · 1 letter Open for comment
- Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I DEA-2026-1585 · 4 letters
- Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V DEA-2026-1321 · 7 letters
- Schedules of Controlled Substances: Placement of Tianeptine in Schedule I DEA-2026-1091 · 3 letters
- Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products DEA-2026-0893 · 1 letter
- Revision of Applications for Manufacturing and Procurement Quotas DEA-2026-0793 · 8 letters
- Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act DEA-2022-0145 · 1 letter
- Controlled Substance Destruction Alternatives to Incineration; Extension of Comment Period DEA-2023-0148 · 9 letters
